Brief: Phathom Pharmaceuticals Reports Q3 2022 Results
08/11/2022 23:18
Nov 8 (Reuters) - Phathom Pharmaceuticals Inc PHAT.O :
* PHATHOM PHARMACEUTICALS REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATES
* QTRLY NET LOSS PER SHARE $1.32
* Q4 EARNINGS PER SHARE VIEW $-1.32 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX9dP1wk
Further company coverage: PHAT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phathom Pharmaceuticals
See all newsBrief: Phathom Pharma Provides Update On Litigation Filed By BDR Pharma Against FDA
Phathom Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Phathom Pharmaceuticals Q2 revenue beats on Voquezna prescription growth
Brief: Phathom Pharmaceuticals Q2 Net Income USD -17.582 Million
Phathom Pharmaceuticals Q1 revenue more than doubles, beats estimates